Side-dependent inhibition of a prokaryotic ClC by DIDS.
Journal: 2006/January - Biophysical Journal
ISSN: 0006-3495
Abstract:
The x-ray structure of the Escherichia coli chloride/proton antiporter ClC-ec1 provides a structural paradigm for the widespread and diverse ClC family of chloride channels and transporters. To maximize the usefulness of this paradigm, it is important to directly relate structure to function via studies of ClC-ec1 itself; however, few functional studies of this protein have been performed. In an endeavor to develop new tools for functional analysis of ClC-ec1, we have discovered that this transporter is inhibited by the stilbenedisulfonate 4,4-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS). In planar lipid bilayers, DIDS inhibits ClC-ec1 activity reversibly, with an apparent affinity in the micromolar range. Since ClC-ec1 is randomly oriented in the bilayers, ascertaining whether DIDS inhibits from the intracellular or extracellular side required an indirect approach. Using the ClC-ec1 structure as a guide, we designed a strategy in which modification of Y445C was monitored in conjunction with inhibition by DIDS. We found that DIDS inhibits transporters specifically from the intracellular side. Transporters with their extracellular side exposed to DIDS function normally, maintaining stoichiometric proton/chloride antiport over a wide range of proton and chloride concentrations. The side-dependent nature of DIDS inhibition will be useful for generating "functionally oriented" preparations of ClC-ec1, in which DIDS is used to silence transporters in one orientation but not the other.
Relations:
Content
Citations
(12)
References
(43)
Drugs
(1)
Chemicals
(7)
Genes
(1)
Organisms
(1)
Processes
(5)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
Biophys J 89(3): 1721-1730

Side-Dependent Inhibition of a Prokaryotic ClC by DIDS

Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, California 94305
Address reprint requests to Merritt Maduke, Dept. of Molecular and Cellular Physiology, B155 Beckman Center, 279 Campus Drive, Stanford, CA 94305. Tel.: 650-723-9075; Fax: 650-725-8021; E-mail: ude.drofnats@ekudam.
Address reprint requests to Merritt Maduke, Dept. of Molecular and Cellular Physiology, B155 Beckman Center, 279 Campus Drive, Stanford, CA 94305. Tel.: 650-723-9075; Fax: 650-725-8021; E-mail: ude.drofnats@ekudam.
Received 2005 May 12; Accepted 2005 Jun 20.

Abstract

The x-ray structure of the Escherichia coli chloride/proton antiporter ClC-ec1 provides a structural paradigm for the widespread and diverse ClC family of chloride channels and transporters. To maximize the usefulness of this paradigm, it is important to directly relate structure to function via studies of ClC-ec1 itself; however, few functional studies of this protein have been performed. In an endeavor to develop new tools for functional analysis of ClC-ec1, we have discovered that this transporter is inhibited by the stilbenedisulfonate 4,4-diisothiocyanatostilbene-2,2′-disulfonic acid (DIDS). In planar lipid bilayers, DIDS inhibits ClC-ec1 activity reversibly, with an apparent affinity in the micromolar range. Since ClC-ec1 is randomly oriented in the bilayers, ascertaining whether DIDS inhibits from the intracellular or extracellular side required an indirect approach. Using the ClC-ec1 structure as a guide, we designed a strategy in which modification of Y445C was monitored in conjunction with inhibition by DIDS. We found that DIDS inhibits transporters specifically from the intracellular side. Transporters with their extracellular side exposed to DIDS function normally, maintaining stoichiometric proton/chloride antiport over a wide range of proton and chloride concentrations. The side-dependent nature of DIDS inhibition will be useful for generating “functionally oriented” preparations of ClC-ec1, in which DIDS is used to silence transporters in one orientation but not the other.

Abstract

Reversal potentials under a wide range of chloride and proton concentrations and gradients. Solutions were buffered with 5 mM citrate-5 mM phosphate. Vrev “unoriented” represents the mean reversal potential ± SD (No. of bilayers) in the absence of DIDS. Vrev “oriented” represents the mean reversal potential ± SD (No. of bilayers) when 2.5 mM DIDS was added to either the cis or the trans chamber. ECl and EH+ represent the calculated reversal potentials for Cl and H, respectively. Activity coefficients of 0.688, 0.818, and 0.940 were used for 300 mM, 40 mM, and 3 mM Cl, respectively (45).

DIDS inhibits ClC-ec1 in a side-dependent manner. Values represent mean ± SD. Numbers in parentheses represent the number of bilayers tested. Conditions were as in Fig. 2, except in some experiments solutions were buffered with 5 mM phosphate in place of 40 mM HEPES. In each case, 2.5 mM DIDS was added to the cis chamber (300 mM KCl pH 5.0), the trans chamber (40 mM KCl pH 5.7), or both. The order of addition did not affect the amount of inhibition. The fact that the reversal potential (Vrev) does not change significantly upon addition of DIDS suggests that much of the residual current after DIDS inhibition is due to currents through ClC-ec1.

Potentiation is defined as the current after addition of MTSET divided by the current before addition of MTSET (mean ± SD). Numbers in parentheses represent the number of bilayers tested. Conditions were as in Fig. 4.

Acknowledgments

We thank Mila Gadzinski for technical assistance and Alessio Accardi and Christopher Miller for graciously donating the Y445C-ClC-ec1 construct and their adventitiously generated variant of BL21-DE3 cells found to contain low levels of contaminating porin channels. We also thank Richard Aldrich, Robert Blaustein, Anita Engh, Anthony Fodor, Weiyan Li, Gilbert Martinez, Joseph Mindell, and Richard Reimer for comments on the manuscript.

This work was supported by the Mathers Foundation and by the Esther Ehrman Lazard Faculty Scholar Award (M.M.). K.M. was supported by the Katherine McCormick Fellowship, the Stanford University School of Medicine Dean's Postdoctoral Award, and the Ruth L. Kirchstein National Research Service Award.

Acknowledgments

References

  • 1. Pusch, M., and T. J. Jentsch. 2005. Unique structure and function of chloride transporting CLC proteins. IEEE Trans Nanobioscience.4:49–57. [[PubMed]
  • 2. Jentsch, T. J., M. Poet, J. C. Fuhrmann, and A. A. Zdebik. 2005. Physiological functions of CLC Cl channels gleaned from human genetic disease and mouse models. Annu. Rev. Physiol.67:779–807. [[PubMed]
  • 3. Jentsch, T. J., C. Lorenz, M. Pusch, and K. Steinmeyer. 1995. Myotonias due to CLC-1 chloride channel mutations. Soc. Gen. Physiol. Ser.50:149–159. [[PubMed]
  • 4. Staley, K., R. Smith, J. Schaack, C. Wilcox, and T. J. Jentsch. 1996. Alteration of GABAA receptor function following gene transfer of the CLC-2 chloride channel. Neuron.17:543–551. [[PubMed]
  • 5. Piwon, N., W. Gunther, M. Schwake, M. R. Bosl, and T. J. Jentsch. 2000. ClC-5 Cl -channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature.408:369–373. [[PubMed]
  • 6. Bosl, M. R., V. Stein, C. Hubner, A. A. Zdebik, S. E. Jordt, A. K. Mukhopadhyay, M. S. Davidoff, A. F. Holstein, and T. J. Jentsch. 2001. Male germ cells and photoreceptors, both dependent on close cell-cell interactions, degenerate upon ClC-2 Cl(−) channel disruption. EMBO J.20:1289–1299.
  • 7. Lipecka, J., M. Bali, A. Thomas, P. Fanen, A. Edelman, and J. Fritsch. 2002. Distribution of ClC-2 chloride channel in rat and human epithelial tissues. Am. J. Physiol. Cell Physiol.282:C805–C816. [[PubMed]
  • 8. Wills, N. K., and P. Fong. 2001. ClC chloride channels in epithelia: recent progress and remaining puzzles. News Physiol. Sci.16:161–166. [[PubMed]
  • 9. Jentsch, T. J. 2005. Chloride transport in the kidney: lessons from human disease and knockout mice. J. Am. Soc. Nephrol.16:1549–1561. [[PubMed]
  • 10. Iyer, R., T. M. Iverson, A. Accardi, and C. Miller. 2002. A biological role for prokaryotic ClC chloride channels. Nature.419:715–718. [[PubMed]
  • 11. Dutzler, R., E. B. Campbell, M. Cadene, B. T. Chait, and R. MacKinnon. 2002. X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature.415:287–294. [[PubMed]
  • 12. Dutzler, R., E. B. Campbell, and R. MacKinnon. 2003. Gating the selectivity filter in ClC chloride channels. Science.300:108–112. [[PubMed]
  • 13. Ludewig, U., M. Pusch, and T. J. Jentsch. 1996. Two physically distinct pores in the dimeric ClC-0 chloride channel. Nature.383:340–343. [[PubMed]
  • 14. Middleton, R. E., D. J. Pheasant, and C. Miller. 1996. Homodimeric architecture of a ClC-type chloride ion channel. Nature.383:337–340. [[PubMed]
  • 15. Saviane, C., F. Conti, and M. Pusch. 1999. The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia. J. Gen. Physiol.113:457–468.
  • 16. Weinreich, F., and T. J. Jentsch. 2001. Pores formed by single subunits in mixed dimers of different CLC chloride channels. J. Biol. Chem.276:2347–2353. [[PubMed]
  • 17. Estevez, R., B. C. Schroeder, A. Accardi, T. J. Jentsch, and M. Pusch. 2003. Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1. Neuron.38:47–59. [[PubMed]
  • 18. Lin, C. W., and T. Y. Chen. 2003. Probing the pore of ClC-0 by substituted cysteine accessibility method using methane thiosulfonate reagents. J. Gen. Physiol.122:147–159.
  • 19. Traverso, S., L. Elia, and M. Pusch. 2003. Gating competence of constitutively open CLC-0 mutants revealed by the interaction with a small organic inhibitor. J. Gen. Physiol.122:295–306.
  • 20. Chen, M. F., and T. Y. Chen. 2003. Side-chain charge effects and conductance determinants in the pore of ClC-0 chloride channels. J. Gen. Physiol.122:133–145.
  • 21. Engh, A. M., and M. Maduke. 2005. Cysteine accessibility in ClC-0 supports conservation of the ClC intracellular vestibule. J. Gen. Physiol.125:601–617.
  • 22. Accardi, A., and C. Miller. 2004. Secondary active transport mediated by a prokaryotic homologue of ClC Cl channels. Nature.427:803–807. [[PubMed]
  • 23. Stein, W. D. 1990. Channels, Carriers, and Pumps. Academic Press, Inc., San Diego, CA.
  • 24. Hanke, W., and C. Miller. 1983. Single chloride channels from Torpedo electroplax. Activation by protons. J. Gen. Physiol.82:25–45.
  • 25. Chen, T. Y., and C. Miller. 1996. Nonequilibrium gating and voltage dependence of the ClC-0 Cl− channel. J. Gen. Physiol.108:237–250.
  • 26. Pusch, M., U. Ludewig, A. Rehfeldt, and T. J. Jentsch. 1995. Gating of the voltage-dependent chloride channel CIC-0 by the permeant anion. Nature.373:527–531. [[PubMed]
  • 27. Pusch, M. 2004. Structural insights into chloride and proton-mediated gating of CLC chloride channels. Biochemistry.43:1135–1144. [[PubMed]
  • 28. Richard, E. A., and C. Miller. 1990. Steady-state coupling of ion-channel conformations to a transmembrane ion gradient. Science.247:1208–1210. [[PubMed]
  • 29. Salhany, J. M. 1996. Allosteric effects in stilbenedisulfonate binding to band 3 protein (AE1). Cell Mol. Biol. (Noisy-le-grand).42:1065–1096. [[PubMed]
  • 30. Romero, M. F., C. M. Fulton, and W. F. Boron. 2004. The SLC4 family of equation M2transporters. Pflugers Arch.447:495–509. [[PubMed]
  • 31. Jentsch, T. J., V. Stein, F. Weinreich, and A. A. Zdebik. 2002. Molecular structure and physiological function of chloride channels. Physiol. Rev.82:503–568. [[PubMed]
  • 32. Cabantchik, Z. I., and R. Greger. 1992. Chemical probes for anion transporters of mammalian cell membranes. Am. J. Physiol.262:C803–C827. [[PubMed]
  • 33. Accardi, A., L. Kolmakova-Partensky, C. Williams, and C. Miller. 2004. Ionic currents mediated by a prokaryotic homologue of CLC Cl channels. J. Gen. Physiol.123:109–119.
  • 34. Heginbotham, L., L. Kolmakova-Partensky, and C. Miller. 1998. Functional reconstitution of a prokaryotic K channel. J. Gen. Physiol.111:741–749.
  • 35. Nozaki, Y., and C. Tanford. 1981. Proton and hydroxide ion permeability of phospholipid vesicles. Proc. Natl. Acad. Sci. USA.78:4324–4328.
  • 36. Mindell, J. A., M. Maduke, C. Miller, and N. Grigorieff. 2001. Projection structure of a ClC-type chloride channel at 6.5 Å resolution. Nature.409:219–223. [[PubMed]
  • 37. Picollo, A., A. Liantonio, M. P. Didonna, L. Elia, D. C. Camerino, and M. Pusch. 2004. Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO Rep.5:584–589.
  • 38. Lewis, R. S., P. E. Ross, and M. D. Cahalan. 1993. Chloride channels activated by osmotic stress in T lymphocytes. J. Gen. Physiol.101:801–826.
  • 39. Helix, N., D. Strobaek, B. H. Dahl, and P. Christophersen. 2003. Inhibition of the endogenous volume-regulated anion channel (VRAC) in HEK293 cells by acidic di-aryl-ureas. J. Membr. Biol.196:83–94. [[PubMed]
  • 40. Thiemann, A., S. Grunder, M. Pusch, and T. J. Jentsch. 1992. A chloride channel widely expressed in epithelial and non-epithelial cells. Nature.356:57–60. [[PubMed]
  • 41. Li, X., K. Shimada, L. A. Showalter, and S. A. Weinman. 2000. Biophysical properties of ClC-3 differentiate it from swelling-activated chloride channels in Chinese hamster ovary-K1 cells. J. Biol. Chem.275:35994–35998. [[PubMed]
  • 42. Mo, L., H. L. Hellmich, P. Fong, T. Wood, J. Embesi, and N. K. Wills. 1999. Comparison of amphibian and human ClC-5: similarity of functional properties and inhibition by external pH. J. Membr. Biol.168:253–264. [[PubMed]
  • 43. Miller, C., and M. M. White. 1980. A voltage-dependent chloride conductance channel from Torpedo electroplax membrane. Ann. N. Y. Acad. Sci.341:534–551. [[PubMed]
  • 44. Miller, C., and M. M. White. 1984. Dimeric structure of single chloride channels from Torpedo electroplax. Proc. Natl. Acad. Sci. USA.81:2772–2775.
  • 45. Robinson, R. A., and R. H. Stokes. 1965. Electrolyte Solutions. Butterworths, London.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.